These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37142139)

  • 1. Modeling of chitosan modified PLGA atorvastatin-curcumin conjugate (AT-CU) nanoparticles, overcoming the barriers associated with PLGA: An approach for better management of atherosclerosis.
    Dash R; Yadav M; Biswal J; Chandra A; Goel VK; Sharma T; Prusty SK; Mohapatra S
    Int J Pharm; 2023 Jun; 640():123009. PubMed ID: 37142139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan Oleate Salt as an Amphiphilic Polymer for the Surface Modification of Poly-Lactic-Glycolic Acid (PLGA) Nanoparticles. Preliminary Studies of Mucoadhesion and Cell Interaction Properties.
    Miele D; Rossi S; Sandri G; Vigani B; Sorrenti M; Giunchedi P; Ferrari F; Bonferoni MC
    Mar Drugs; 2018 Nov; 16(11):. PubMed ID: 30445668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chitosan-Coated PLGA Nanoparticles for Enhanced Ocular Anti-Inflammatory Efficacy of Atorvastatin Calcium.
    Arafa MG; Girgis GNS; El-Dahan MS
    Int J Nanomedicine; 2020; 15():1335-1347. PubMed ID: 32184589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in vitro evaluation of surface modified poly(lactide-co-glycolide) nanoparticles with chitosan-4-thiobutylamidine.
    Grabovac V; Bernkop-Schnürch A
    Drug Dev Ind Pharm; 2007 Jul; 33(7):767-74. PubMed ID: 17654025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levofloxacin loaded chitosan and poly-lactic-co-glycolic acid nano-particles against resistant bacteria: Synthesis, characterization and antibacterial activity.
    Hayee R; Iqtedar M; Albekairi NA; Alshammari A; Makhdoom MA; Islam M; Ahmed N; Rasool MF; Li C; Saeed H
    J Infect Public Health; 2024 May; 17(5):906-917. PubMed ID: 38569270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chitosan Oleate Coated Poly Lactic-Glycolic Acid (PLGA) Nanoparticles versus Chitosan Oleate Self-Assembled Polymeric Micelles, Loaded with Resveratrol.
    Miele D; Catenacci L; Sorrenti M; Rossi S; Sandri G; Malavasi L; Dacarro G; Ferrari F; Bonferoni MC
    Mar Drugs; 2019 Sep; 17(9):. PubMed ID: 31480614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The remarkable role of emulsifier and chitosan, dextran and PEG as capping agents in the enhanced delivery of curcumin by nanoparticles in breast cancer cells.
    Sampath M; Pichaimani A; Kumpati P; Sengottuvelan B
    Int J Biol Macromol; 2020 Nov; 162():748-761. PubMed ID: 32585267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mucoadhesive chitosan-poly (lactic-co-glycolic acid) nanoparticles for intranasal delivery of quetiapine - Development & characterization in physiologically relevant 3D tissue models.
    Gadhave DG; Quadros M; Ugale AR; Goyal M; Ayehunie S; Gupta V
    Int J Biol Macromol; 2024 May; 267(Pt 2):131491. PubMed ID: 38599435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced.
    Song X; Wang J; Xu Y; Shao H; Gu J
    Colloids Surf B Biointerfaces; 2019 Aug; 180():110-117. PubMed ID: 31030022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Anti-Proliferative Effect of Carboplatin in Ovarian Cancer Cells Exploiting Chitosan-Poly (Lactic Glycolic Acid) Nanoparticles.
    Alassaif FR; Alassaif ER; Kaushik AK; Dhanapal J
    Recent Pat Nanotechnol; 2023; 17(1):74-82. PubMed ID: 35021983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery.
    Asal HA; Shoueir KR; El-Hagrasy MA; Toson EA
    Int J Biol Macromol; 2022 Jun; 209(Pt B):2188-2196. PubMed ID: 35504421
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang L; Yang S; Wong LR; Xie H; Ho PC
    Mol Pharm; 2020 Nov; 17(11):4256-4269. PubMed ID: 33084343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation, characterization, and in vitro and in vivo investigation of chitosan-coated poly (d,l-lactide-co-glycolide) nanoparticles for intestinal delivery of exendin-4.
    Wang M; Zhang Y; Feng J; Gu T; Dong Q; Yang X; Sun Y; Wu Y; Chen Y; Kong W
    Int J Nanomedicine; 2013; 8():1141-54. PubMed ID: 23658482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scale up, optimization and stability analysis of Curcumin C3 complex-loaded nanoparticles for cancer therapy.
    Ranjan AP; Mukerjee A; Helson L; Vishwanatha JK
    J Nanobiotechnology; 2012 Aug; 10():38. PubMed ID: 22937885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-acting inhalable chitosan-coated poly(lactic-co-glycolic acid) nanoparticles containing hydrophobically modified exendin-4 for treating type 2 diabetes.
    Lee C; Choi JS; Kim I; Oh KT; Lee ES; Park ES; Lee KC; Youn YS
    Int J Nanomedicine; 2013; 8():2975-83. PubMed ID: 23976850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro-in vivo evaluation of chitosan-PLGA nanoparticles for potentiated gastric retention and anti-ulcer activity of diosmin.
    Abd El Hady WE; Mohamed EA; Soliman OAE; El-Sabbagh HM
    Int J Nanomedicine; 2019; 14():7191-7213. PubMed ID: 31564873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of modular polymeric nanoparticles for drug delivery using amine reactive chemistry.
    Wong C; Ho EA
    J Pharm Pharm Sci; 2024; 27():13148. PubMed ID: 39165831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison and process optimization of PLGA, chitosan and silica nanoparticles for potential oral vaccine delivery.
    Amin MK; Boateng JS
    Ther Deliv; 2019 Aug; 10(8):493-514. PubMed ID: 31496377
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.